Giovanni Paolino, MD

Article

Skin Lesions in Patients Treated With Imatinib Mesylate: A 5-Year Prospective Study

Author:

Giovanni Paolino, MD

Dario Didona, MD

Rita Clerico, MD

Paola Corsetti, MD

Marina Ambrifi, MD

Ugo Bottoni, PhD

Stefano Calvieri, PhD

Imatinib mesylate (IM) represents the first-line treatment of patients with chronic myeloid leukemia (CLM) or gastrointestinal stromal tumor (GIST...

• Read More